PDCD1 and hepatocellular carcinoma: The study included 26 patients with previously untreated HCC and 26 patients with HCC treated with the triple therapy of local therapy combined with lenvatinib and PD-1 inhibitors and analyzed the microbiological communities by 16S rRNA gene amplicon sequencing.